A groundbreaking treatment has been announced for women with an extremely aggressive form of breast cancer. Siteman Cancer ...

A 49-year-old scientist successfully treated her breast cancer by using a virus she grew in the lab. Her self-treatment ...

The phase 2 INVINCIBLE-4 clinical trial is currently underway in patients with localized triple-negative breast cancer.

Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...

News in early breast cancer this year was marked by updated U.S. Preventive Services Task Force (USPSTF) screening ...

New Therapeutic Strategy Identified for Triple Negative Breast Cancer Oct ... System Target to Head Off the Spread of Breast Cancer Cells Sep. 3, 2024 — In a study using human breast cancer ...

Hodgkin's lymphoma in October The post Dave Coulier Reveals Stage 3 Cancer Diagnosis: ‘This Has Been a Really Fast Roller ...

Patients with early-stage triple-negative breast cancer (TNBC) and high immune infiltration ... a randomized phase 3 clinical trial, to identify the specific population that benefited from ...

People living in long-impoverished areas are more likely to have aggressive or advanced breast cancer, undergo the most ...

(KTLA) — Dave Coulier has been diagnosed with Stage 3 Non-Hodgkin lymphoma ... The discussion of cancer, sadly, isn’t new to ...

After his diagnosis, Coulier quickly joined forces with close friends in medicine and his wife to meet the cancer “head-on,” ...

The FDA recently approved the combination of inavolisib, fulvestrant, and palbociclib in this patient population.